R&D Multilateral benefit sharing mechanism for digital sequence ... Since December 2022, and COP decision 15/9, members of the Convention on Biolog
R&D Sponsored Completing a successful tech transfer Tech transfers can be difficult and every one is unique, but the right tips can help. Lannett CDMO's Grant Brock and Frantz Maignan weigh in.
News Servier snaps up cancer biotech Day One in $2.5bn deal Servier has made a takeover offer for Day One and its fast-growing glioma therapy Ojemda, as it pitches to drive sales above €10bn by 2030.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
